These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy. Meijer HJ; van Lin EN; Debats OA; Witjes JA; Span PN; Kaanders JH; Barentsz JO Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1405-10. PubMed ID: 21640507 [TBL] [Abstract][Full Text] [Related]
10. Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan. Otta-Oshiro RJ; Lista-Mateos F; García-Mediero J; Arranz-Arija JA; García-Prado J; Núñez-Mora C Actas Urol Esp (Engl Ed); 2019; 43(6):331-335. PubMed ID: 30975547 [TBL] [Abstract][Full Text] [Related]
11. [Extended salvage pelvic and retroperitoneal lymph node dissection due to prostate cancer relapse]. Osmonov DK; Aksenov AV; Jünemann KP Aktuelle Urol; 2013 Jan; 44(1):50-2. PubMed ID: 23325670 [TBL] [Abstract][Full Text] [Related]
12. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure? Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322 [TBL] [Abstract][Full Text] [Related]
13. Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes. Linxweiler J; Saar M; Al-Kailani Z; Janssen M; Ezziddin S; Stöckle M; Siemer S; Ohlmann CH Surg Oncol; 2018 Jun; 27(2):138-145. PubMed ID: 29937163 [TBL] [Abstract][Full Text] [Related]
14. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy. Oderda M; Joniau S; Palazzetti A; Falcone M; Melloni G; Van Den Bossche H; Deconinck S; Zattoni F; Karnes RJ; Gontero P Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893 [TBL] [Abstract][Full Text] [Related]
15. Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy. Abdollah F; Briganti A; Montorsi F; Stenzl A; Stief C; Tombal B; Van Poppel H; Touijer K Eur Urol; 2015 May; 67(5):839-49. PubMed ID: 24698524 [TBL] [Abstract][Full Text] [Related]
16. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]
17. Management of positive lymph nodes following radical prostatectomy. Heidenreich A; Rieke M; Mahjoub S; Pfister D Arch Esp Urol; 2019 Mar; 72(2):182-191. PubMed ID: 30855020 [TBL] [Abstract][Full Text] [Related]